BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 1348231)

  • 1. Complications associated with ulcer recurrence following gastric surgery for ulcer disease.
    Penston JG; Boyd EJ; Wormsley KG
    Gastroenterol Jpn; 1992 Feb; 27(1):129-41. PubMed ID: 1348231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical versus surgical treatment for refractory or recurrent peptic ulcer.
    Gurusamy KS; Pallari E
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011523. PubMed ID: 27025289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indications and results of surgical treatment of ulcers. Considerations after the introduction of H2-receptor antagonists].
    Barner S; Waldmann D; Farthmann EH
    Fortschr Med; 1984 Jul; 102(25-26):692-6. PubMed ID: 6147305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of peptic ulcer disease.
    Sachdeva AK; Zaren HA; Sigel B
    Med Clin North Am; 1991 Jul; 75(4):999-1012. PubMed ID: 2072800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Late complications after surgical operations in gastroduodenal ulcer (emergency operations)].
    Popovici G; Dop R
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1980; 29(2):115-21. PubMed ID: 6447325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A decade of experience with long-term continuous treatment of peptic ulcers with H2-receptor antagonists.
    Penston JG
    Aliment Pharmacol Ther; 1993; 7 Suppl 2():27-33. PubMed ID: 8103373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery for peptic ulcer disease in children in the post-histamine2-blocker era.
    Edwards MJ; Kollenberg SJ; Brandt ML; Wesson DE; Nuchtern JG; Minifee PK; Cass DL
    J Pediatr Surg; 2005 May; 40(5):850-4. PubMed ID: 15937829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antrectomy and gastroduodenostomy with or without vagotomy in peptic ulcer disease. A prospective study with a 5-year follow-up.
    Rehnberg O
    Acta Chir Scand Suppl; 1983; 515():1-63. PubMed ID: 6579806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptic ulcer surgery during the H2-receptor antagonist era: a population-based epidemiological study of ulcer surgery in Helsinki from 1972 to 1987.
    Paimela H; Tuompo PK; Peräkyl T ; Saario I; Höckerstedt K; Kivilaakso E
    Br J Surg; 1991 Jan; 78(1):28-31. PubMed ID: 1671826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent ulceration after highly selective vagotomy for duodenal ulcer.
    Blackett RL; Johnston D
    Br J Surg; 1981 Oct; 68(10):705-10. PubMed ID: 7025957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reoperation for postsurgical peptic ulcer recurrence: appraisal of ten years' experience.
    Neustein CL; Bushkin FL; Weinshelbaum EI; Woodward ER
    Ann Surg; 1977 Feb; 185(2):169-74. PubMed ID: 836088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic and health aspects of peptic ulcer disease and H2-receptor antagonists.
    Jensen DM
    Am J Med; 1986 Oct; 81(4B):42-8. PubMed ID: 2877574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent ulcer after gastric surgery--prevention and management based on a local experience.
    Ti TK
    Ann Acad Med Singap; 1983 Oct; 12(4):564-9. PubMed ID: 6146288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in ulcer surgery following introduction of H2-blockers].
    Paimela H; Kivilaakso E; Tuompo P; Peräkylä T; Höckerstedt K; Saarlo I
    Nord Med; 1991; 106(6-7):198-201. PubMed ID: 1677178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical therapy in the treatment concept of ulcer disease. A critical evaluation].
    Winkeltau G; Arlt G; Treutner KH; Schumpelick V
    Leber Magen Darm; 1988 Sep; 18(5):229-35. PubMed ID: 2903423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of childhood duodenal ulcers.
    Chan KL; Tam PK; Saing H
    J Pediatr Surg; 1997 Nov; 32(11):1609-11. PubMed ID: 9396537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Initial interventions in ulcer disease: indications--choice of procedure--results].
    Peitsch W
    Langenbecks Arch Chir; 1987; 372():173-9. PubMed ID: 3431235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proximal gastric vagotomy, truncal vagotomy with drainage, and truncal vagotomy with antrectomy for chronic duodenal ulcer. A prospective, randomized controlled trial.
    Koo J; Lam SK; Chan P; Lee NW; Lam P; Wong J; Ong GB
    Ann Surg; 1983 Mar; 197(3):265-71. PubMed ID: 6338842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: maintenance treatment with H2-receptor antagonists for peptic ulcer disease.
    Penston JG; Wormsley KG
    Aliment Pharmacol Ther; 1992 Feb; 6(1):3-29. PubMed ID: 1347467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Personal experience with gastric resection in the treatment of gastroduodenal ulcer].
    Conti A; Saviano MS
    Minerva Chir; 1978 Apr; 33(7):385-90. PubMed ID: 652183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.